IS7415A - N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma - Google Patents
N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdómaInfo
- Publication number
- IS7415A IS7415A IS7415A IS7415A IS7415A IS 7415 A IS7415 A IS 7415A IS 7415 A IS7415 A IS 7415A IS 7415 A IS7415 A IS 7415A IS 7415 A IS7415 A IS 7415A
- Authority
- IS
- Iceland
- Prior art keywords
- difluorobenzyl
- methylsulfonyl
- ylmethyl
- acetamide
- morpholine
- Prior art date
Links
- NDZYPHLNJZSQJY-QNWVGRARSA-N 1-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-3-[(1r,2s)-2-[[(3s)-3-[(4-fluorophenyl)methyl]piperidin-1-yl]methyl]cyclohexyl]urea Chemical compound CC1=C(C(=O)C)SC(NC(=O)N[C@H]2[C@@H](CCCC2)CN2C[C@H](CC=3C=CC(F)=CC=3)CCC2)=N1 NDZYPHLNJZSQJY-QNWVGRARSA-N 0.000 title 1
- 125000006509 3,4-difluorobenzyl group Chemical group [H]C1=C(F)C(F)=C([H])C(=C1[H])C([H])([H])* 0.000 title 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207449.0A GB0207449D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
| PCT/EP2003/003339 WO2003082291A1 (en) | 2002-03-28 | 2003-03-27 | N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7415A true IS7415A (is) | 2004-08-19 |
Family
ID=9933998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7415A IS7415A (is) | 2002-03-28 | 2004-08-19 | N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20060058299A1 (https=) |
| EP (1) | EP1487453B1 (https=) |
| JP (1) | JP4490110B2 (https=) |
| KR (1) | KR20040095347A (https=) |
| CN (1) | CN1642553A (https=) |
| AR (1) | AR039177A1 (https=) |
| AT (1) | ATE454892T1 (https=) |
| AU (1) | AU2003216905A1 (https=) |
| BR (1) | BR0308719A (https=) |
| CA (1) | CA2479910A1 (https=) |
| DE (1) | DE60330952D1 (https=) |
| ES (1) | ES2339436T3 (https=) |
| GB (1) | GB0207449D0 (https=) |
| IL (1) | IL163648A0 (https=) |
| IS (1) | IS7415A (https=) |
| MX (1) | MXPA04009458A (https=) |
| NO (1) | NO20044098L (https=) |
| PL (1) | PL372930A1 (https=) |
| RU (1) | RU2004126145A (https=) |
| TW (1) | TW200400823A (https=) |
| WO (1) | WO2003082291A1 (https=) |
| ZA (1) | ZA200406990B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004028530A1 (en) | 2002-09-26 | 2004-04-08 | Bristol-Myers Squibb Company | N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| WO2007011292A1 (en) * | 2005-07-21 | 2007-01-25 | Astrazeneca Ab | N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
| HUP0500886A2 (en) * | 2005-09-23 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use |
| HUP0500877A2 (en) * | 2005-09-22 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates |
| BRPI0616150A2 (pt) * | 2005-09-22 | 2011-06-07 | Sanofi Aventis | derivados de amino-alquil-amida como lìquidos receptores de ccr3 |
| HUP0800478A2 (en) * | 2008-07-31 | 2010-03-01 | Sanofi Aventis | Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands |
| EP2785338A1 (en) * | 2011-12-01 | 2014-10-08 | Glaxo Group Limited | Methods of treatment and prevention of eye diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS562929A (en) * | 1979-06-21 | 1981-01-13 | Sumitomo Chem Co Ltd | Preparation of optically active cyclopentenolone |
| CZ284687B6 (cs) * | 1986-04-30 | 1999-02-17 | Dainippon Pharmaceutical Co., Ltd. | Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi |
| JPH01117882A (ja) * | 1987-10-30 | 1989-05-10 | Dainippon Pharmaceut Co Ltd | 複素環式カルボン酸アミド誘導体 |
| JPH03291274A (ja) * | 1990-04-09 | 1991-12-20 | Yoshitomi Pharmaceut Ind Ltd | アミノアルキルモルホリン誘導体の製造法 |
| JPH04270272A (ja) * | 1991-02-25 | 1992-09-25 | Yoshitomi Pharmaceut Ind Ltd | アミノアルキルモルホリン誘導体の製造法 |
| TW223629B (https=) * | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
| US5219856A (en) * | 1992-04-06 | 1993-06-15 | E. I. Du Pont De Nemours And Company | Angiotensin-II receptor blocking, heterocycle substituted imidazoles |
| US6031097A (en) * | 1997-10-27 | 2000-02-29 | Neurogen Corporation | 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
| US6331545B1 (en) * | 1998-12-18 | 2001-12-18 | Soo S. Ko | Heterocycyclic piperidines as modulators of chemokine receptor activity |
| HUP0202712A3 (en) * | 1999-09-14 | 2004-12-28 | Aventis Pharmaceuticals Inc Br | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing the compounds |
| EP1324990B1 (en) * | 2000-09-29 | 2014-10-29 | Glaxo Group Limited | Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| BR0114321A (pt) * | 2000-09-29 | 2003-07-01 | Glaxo Group Ltd | Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto |
-
2002
- 2002-03-28 GB GBGB0207449.0A patent/GB0207449D0/en not_active Ceased
-
2003
- 2003-03-26 TW TW092106782A patent/TW200400823A/zh unknown
- 2003-03-27 KR KR10-2004-7015447A patent/KR20040095347A/ko not_active Withdrawn
- 2003-03-27 CN CNA038068656A patent/CN1642553A/zh active Pending
- 2003-03-27 DE DE60330952T patent/DE60330952D1/de not_active Expired - Lifetime
- 2003-03-27 BR BR0308719-0A patent/BR0308719A/pt not_active Application Discontinuation
- 2003-03-27 PL PL03372930A patent/PL372930A1/xx not_active Application Discontinuation
- 2003-03-27 CA CA002479910A patent/CA2479910A1/en not_active Abandoned
- 2003-03-27 AR ARP030101090A patent/AR039177A1/es unknown
- 2003-03-27 RU RU2004126145/04A patent/RU2004126145A/ru not_active Application Discontinuation
- 2003-03-27 ES ES03712117T patent/ES2339436T3/es not_active Expired - Lifetime
- 2003-03-27 AU AU2003216905A patent/AU2003216905A1/en not_active Abandoned
- 2003-03-27 IL IL16364803A patent/IL163648A0/xx unknown
- 2003-03-27 WO PCT/EP2003/003339 patent/WO2003082291A1/en not_active Ceased
- 2003-03-27 EP EP03712117A patent/EP1487453B1/en not_active Expired - Lifetime
- 2003-03-27 US US10/509,417 patent/US20060058299A1/en not_active Abandoned
- 2003-03-27 AT AT03712117T patent/ATE454892T1/de not_active IP Right Cessation
- 2003-03-27 JP JP2003579828A patent/JP4490110B2/ja not_active Expired - Lifetime
- 2003-03-27 MX MXPA04009458A patent/MXPA04009458A/es unknown
-
2004
- 2004-08-19 IS IS7415A patent/IS7415A/is unknown
- 2004-09-01 ZA ZA200406990A patent/ZA200406990B/en unknown
- 2004-09-27 NO NO20044098A patent/NO20044098L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4490110B2 (ja) | 2010-06-23 |
| PL372930A1 (en) | 2005-08-08 |
| NO20044098L (no) | 2004-10-04 |
| ATE454892T1 (de) | 2010-01-15 |
| WO2003082291A1 (en) | 2003-10-09 |
| ZA200406990B (en) | 2005-11-08 |
| US20060058299A1 (en) | 2006-03-16 |
| BR0308719A (pt) | 2005-01-04 |
| IL163648A0 (en) | 2005-12-18 |
| CN1642553A (zh) | 2005-07-20 |
| TW200400823A (en) | 2004-01-16 |
| CA2479910A1 (en) | 2003-10-09 |
| JP2005525390A (ja) | 2005-08-25 |
| GB0207449D0 (en) | 2002-05-08 |
| EP1487453B1 (en) | 2010-01-13 |
| AR039177A1 (es) | 2005-02-09 |
| ES2339436T3 (es) | 2010-05-20 |
| KR20040095347A (ko) | 2004-11-12 |
| DE60330952D1 (de) | 2010-03-04 |
| RU2004126145A (ru) | 2005-06-27 |
| MXPA04009458A (es) | 2005-07-27 |
| AU2003216905A1 (en) | 2003-10-13 |
| EP1487453A1 (en) | 2004-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2009013I1 (el) | Νεα χρηση μιας ενωσης πεπτιδικης κατηγοριας για τη θεραπεια του μη νευροπαθους φλεγμονωδους πονου | |
| EP1589981A4 (en) | INTERFERON ANTAGONISTS FOR THE TREATMENT OF DISEASES RELATED TO INTERFERON | |
| ATE361279T1 (de) | N-[phenyl(piperidin-2-yl)methyl]benzamidderivat , verfahren zu ihrer herstellung und ihre therapeutische anwendung | |
| DK1575597T3 (da) | Anvendelse af rimexolon til behandling af öjentörhed | |
| EP1696784A4 (en) | BIOKONJUGATED NANOSTRUCTURES, METHOD FOR THE PRODUCTION THEREOF AND METHOD OF APPLICATION THEREFOR | |
| DK1944322T3 (da) | Behandling af TNFalfa-relaterede sygdomme | |
| EP1702683A4 (en) | Metal oxynitride electrode catalyst | |
| ATE381263T1 (de) | Fungizide zusammensetzungen, die n-(alpha-cyano-2-thenyl)-4-ethyl-2-ethylamino-5 thiazolcarboxamide enthalten | |
| EP1568691A4 (en) | ACCELERATOR FOR ERYTHROPOETIN PRODUCTION | |
| IS7415A (is) | N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma | |
| IS7609A (is) | 2,5-tvíútskipt 3-merkaptópentansýra | |
| NO20025964D0 (no) | Ny interferon for behandling av multippel sklerose | |
| ITMI20032172A1 (it) | Procedimento atto alla correzione dell'arricchimento di | |
| EP1550533A4 (en) | IMPACT-ABSORBING MECHANISM FOR SCREAMING ROBOT | |
| EP1501350A4 (en) | ACTIVATION OF HORSE OOCYTES | |
| ITMI20021277A1 (it) | Perfluoropolieteri comprendenti unita' ripetitive ottenute dall'ossidazione di perfluorodiossoli | |
| DK1284722T3 (da) | Sammensætninger indeholdende et benzamiddisulfidderivat til behandling af allergiske sygdomme | |
| ITBO20020103A1 (it) | Macchina ginnica con controllo delle prestazioni dell'utilizzatore | |
| EP1585480A4 (en) | ERBB4 CO CRYSTAL | |
| HK1071699A (en) | N-[(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl]methyl-2-3-[(methylsulphonyl)amino]phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions | |
| FR2852042B1 (fr) | Piece d'aretier | |
| ITRM20030573A1 (it) | Dispositivo per la regolazione dell'orientamento di un | |
| RU2002103167A (ru) | Кардиопротекторное средство | |
| SE0201766D0 (sv) | Golftillbehör "Greenlagare" | |
| ES1052456Y (es) | "tacos silenciadores autoadhesibles" |